Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Carmustine · Gliadel, BCNU

Small molecule · Cytotoxic, directed at DNA · developed by Avet Lifesciences

Approved FDA, Mar 1977
2 Registered trials

What is Carmustine?

Carmustine is a nitrosourea alkylating agent that cross-links DNA and carbamoylates proteins, including DNA repair enzymes, producing cytotoxic effects. It crosses the blood-brain barrier readily. It is studied in pancreatic cancer and breast cancer, among other cancers.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Gliadel, BCNU, DTI-015, FDA-0345
Drug type
Small molecule
Targets
DNA, RNA (secondary target)
Mechanism
Cytotoxic, directed at DNA
Pathways
DNA alkylation and cross-linking, protein carbamoylation, apoptosis, cell cycle arrest
Therapy area
Oncology
Developer
Avet Lifesciences
In trials of
LSTA, MYGN
FDA status
Approved as Gliadel (March 7, 1977), NDA017422 · FDA label
UNII
U68WG3173Y

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT00814593 Phase 2 Brain and Central Nervous System Tumors Withdrawn LSTA
NCT04150042 Phase 1 Pancreatic Adenocarcinoma Metastatic Recruiting MYGN

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Adenocarcinoma of the BreastBRCA1 MutationBRCA2 MutationBreast Cancer MetastaticBreast Cancer Stage IVHER2 Negative Breast CarcinomaHER2-negative Breast CancerMetastatic Pancreatic CancerMetastatic Pancreatic Ductal AdenocarcinomaPALB2 Gene MutationPancreatic Acinar Cell CarcinomaPancreatic Adenocarcinoma MetastaticPancreatic CancerPancreatic Cancer Stage IV

Sources

Updated Oct 25, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.